Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 10Terminated 3Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Anemia 3

Interventions

Epoetin Alfa 9Darbepoetin alfa 5epoetin beta 3telapristone acetate 2fludarabine phosphate 2fludarabine 2Cyclophosphamide 2Carboplatin 2Busulfan 2AP 1903 reagent 2ACE-011 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1vactosertib 1trametinib 1thymoglobulin 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1peginesatide 1palbociclib 1olaparib 1niraparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1hematide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Anemia × epoetin beta × Clear all
NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated
27 enrolled
Classical hematology

Anemia

NCT02608060 2016-11-02

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Hoffmann-La Roche

Phase 4 Terminated
4 enrolled
Classical hematology

Anemia

NCT02624141 2016-11-02

A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Hoffmann-La Roche

Phase 4 Terminated
10 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡